These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 737968)

  • 21. [Changes in plasma lipids in normal subjects in relation to age and sex. 3. Total lipids, triglycerides, phospholipids, alpha- and beta-lipoproteic cholesterol and single NEFA (C16-C18) in pre-senile subjects].
    Bertolini AM; Santagostino A
    G Gerontol; 1972 Mar; 20(3):217-27. PubMed ID: 5030359
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of oxandrolone on the serum lipids in type IV and IIb hyperlipidemia].
    Zorrilla E; Magos C; Serrano PA
    Arch Inst Cardiol Mex; 1973; 43(2):270-8. PubMed ID: 4712792
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lipid studies in myocardial infarct, angina pectoris and obliterating arteriosclerosis].
    Rechenberger J; Kröning G
    Z Gesamte Inn Med; 1973 Dec; 28(23):728-33. PubMed ID: 4362267
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in plasma lipids in relation to age and sex in normal subjects. I. Total lipids, triglycerides, phospholipids, single NEFA (C 16 -C 18 ), alpha-beta lipoproteic cholesterol in young adults].
    Bertolini AM; Santagostino A
    G Gerontol; 1971 Aug; 19(8):558-66. PubMed ID: 5141160
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of triiodothyronine on blood lipids in obesity.
    Kader MM; Kamel G; Aziz MT; Kenawy MM; el-Sadani MM; Erfan A; Madwar KR; Sherif N
    Acta Biol Med Ger; 1975; 34(9):1465-9. PubMed ID: 1221734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC; Ahuja MM
    Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract]   [Full Text] [Related]  

  • 29. [On some aspects of the dynamics of post-alimentary lipid transport following the intravenous administration of essential phospholipids].
    Pedini G; Gherson G
    Clin Ter; 1967 Oct; 43(1):49-72. PubMed ID: 5605580
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of long-term treatment with fenofibrate on serum lipids and lipoproteins in patients with hypercholesterolemia and hypertriglyceridemia].
    Sznajderman M
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1633-7. PubMed ID: 3588382
    [No Abstract]   [Full Text] [Related]  

  • 31. [Some metabolic aspects of senescence].
    Sgambato S; Drammis E; Rufino G
    G Gerontol; 1968 Aug; 16(8):837-45. PubMed ID: 5740962
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lipids and arteriosclerosis].
    Carmena R
    Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of essential phospholipids (Essliver Forte) on the level of cholesterol and blood serum lipoproteins in bile duct diseases].
    Kozlova NM; Tiuriumin IaL; Kulinskiĭ VI; Leonova ZA
    Eksp Klin Gastroenterol; 2006; (6):73-6. PubMed ID: 17612099
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plasmatic lipid pattern in the obese: total lipids, triglycerides, phospholipids, alpha and beta lipoproteic cholesterol and single NEFA (C16-C18)].
    Bertolini AM; Santagostino A
    Minerva Med; 1973 Apr; 64(27):1429-37. PubMed ID: 4708214
    [No Abstract]   [Full Text] [Related]  

  • 36. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary research on the effects of administration of CoA on plasmatic lipids in humans].
    Arrigo F; Vitale D; Consolo F
    Clin Ter; 1974 Dec; 71(5):459-68. PubMed ID: 4452226
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in the lipid and lipoprotein pattern in patients with primary gout].
    Marcolongo R; Riario-Sforza G; Baccarini V
    Reumatismo; 1975; 27(1):180-5. PubMed ID: 1233631
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum lipids of health persons].
    Schönbeck M; Jakab T; Risch D; Werning C; Lüthy R; Knob M; Rosenmund H; Siegenthaler W
    Med Klin; 1970 Apr; 65(14):644-9. PubMed ID: 5507796
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in plasma lipids in diabetes mellitus].
    Avogaro P; Capri C; Cazzolato G; Pais M
    Minerva Med; 1975 Oct; 66(65):3388-96. PubMed ID: 809727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.